We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
23.50 | 1.38% | 1,728.50 | 1,727.50 | 1,728.50 | 1,729.50 | 1,695.50 | 1,705.00 | 6,275,082 | 16:35:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.44 | 71.14B |
Date | Subject | Author | Discuss |
---|---|---|---|
20/10/2020 11:21 | Always good to keep abreast of the competition... 19th Oct'20:-"Pfizer and Moderna pivotal studies on COVID-19 vaccines near enrollment targets" As of today, Pfizer/BioNTech's&nb As of Friday, October 16, Moderna has enrolled 29,521 participants in its 30K-subject Phase 3 study of mRNA-1273, 24,496 of which have received the second jab. "Moderna not far behind Pfizer on vaccine emergency authorization" The U.S. could authorize emergency use of Moderna's (NASD The comments suggest Moderna's timetable isn't that far off from Pfizer's (NYSE: Pfizer, which is working with Germany's BioNTech (NASDA | geckotheglorious | |
20/10/2020 09:38 | Ok thanks arja... waiting waiting then so | bogman1 | |
20/10/2020 07:45 | chart shows a clear downtrend and hence not smart to add yet IMO . About 1350 seems to be support level but charts are not an exact science but next best thing to a crystal ball which are too expensive to buy ! | arja | |
19/10/2020 19:35 | Just right. Looking to add myself on this. Sub 14 is a ridiculously low price. | bogman1 | |
19/10/2020 15:40 | I've been adding today, the S/P will only get better, plus the Divi not bad either. | igoe104 | |
18/10/2020 20:18 | I was a couple of hours early with my investment on Thursday, but pleased with the rebound on Friday. With the Pfizer news, pharma stocks should see sharp rises in the coming weeks. | shammytime | |
18/10/2020 11:07 | Lol, that's why your never hear of a rich chartist. | montyhedge | |
16/10/2020 21:47 | Double head n shoulder no dandruff | williamcooper104 | |
16/10/2020 21:31 | Old Chinese ploverb say : Man with 2 legs walk faster than man with one....Hard to argue. spud | spud | |
16/10/2020 20:42 | Tea leaves say............. | badtime | |
16/10/2020 19:50 | Chart says 1300. | djb3 | |
16/10/2020 18:02 | jade - historical reasons if I may ask? My bearish positions were slightly larger at one time. ;)) | alphorn | |
16/10/2020 17:17 | And imo .. will go to 1500 ! Then make a decision | amaretto1 | |
16/10/2020 17:15 | It played the chart spot on to 13.75It should carry on riseing from here. | amaretto1 | |
16/10/2020 17:02 | GSK is if anything negatively correlated to the Great British Peso Will have a higher GBP cost base which will be less relative to its much larger USD and EUR revenue streams There's a lot of US life science interest in the U.K. which is based on our scientists being cheaper in USD terms and likely to get cheaper | williamcooper104 | |
16/10/2020 16:57 | Glaxo is U.K. listed and headquartered - but that's it - not a domestic company | williamcooper104 | |
16/10/2020 16:55 | Inflation resilient assets and a good accountant | williamcooper104 | |
16/10/2020 16:39 | Porsche, lol, his got a skateboard. | montyhedge | |
16/10/2020 16:27 | Spent it all attempting to keep his ropey Porsche 924 on the road.....spud | spud | |
16/10/2020 15:33 | Lol he has not got one single share. His a dreamer. | montyhedge | |
16/10/2020 15:32 | P1945, can’t understand why you own so many GSK shares ( you said you had many more than me and I own more than £0.5 million worth) and yet you always seem to berate them! | jadeticl3 | |
16/10/2020 15:16 | Does it cannibalise current treatment? (Not belittling the positive impact for patients). | alphorn | |
16/10/2020 15:07 | In a normal market, with that rns these would have been 1550p. | montyhedge |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions